News 2024-03-08
Join Our Founder and CEO @ DCAT Week
Join Our Founder and CEO @ DCAT Week
What:
DCAT Member Company Announcement Forum
When:
10:36-10:43AM, on Monday March 18, 2024
Where:
InterContinental Barclay, Grand Ballroom (2nd Floor)
Porton Pharma Solutions Ltd (hereinafter referred to as Porton or the Company) will participate in the DCAT Week which will be held in New York, from March 18-21, 2024.
As the premiere event in New York City for the Global Bio/Pharmaceutical Manufacturing Value Chain, DCAT Week garners annual industry attention. Porton has consistently participated in this esteemed gathering. At this year’s conference, our Chairman & CEO, Oliver Ju, is scheduled to speak at the DCAT Member Company Announcement Forum on the opening day. He will unveil our latest European and US facilities and capabilities, highlighting how these expansions streamline and enhance our ability to meet your unique development needs with greater ease.
Throughout DCAT Week, the Porton management team, our business development (BD) specialists, and our scientists are eager to connect with you in New York.
Schedule a meeting with us: Arsalan Khan
Others
More
News 2025-07-31
NMPA Approves Jike Shu (Sebaloxavir Marboxil Tablets) for the Treatment of Uncomplicated Influenza in Adults
Self-developed novel PA endonuclease inhibitor anti-influenza drug Jike Shu (Sebaloxavir Marboxil Tablets) has officially received marketing approval from China's National Medical Products Administration (NMPA) for the treatment of uncomplicated influenza in adults.
News 2025-07-31
Porton and Repare Therapeutics Collaborate on OPRD Publication, Demonstrating Strength in Synthetic Process Development and Optimization
Overcoming the challenge of efficient synthesis of PKMYT1 inhibitor Lunresertib
